Growth Hormone Protects the Intestine Preserving Radiotherapy Efficacy on Tumors: A Short-Term Study

被引:9
作者
Caz, Victor [1 ]
Elvira, Marcos [1 ]
Tabernero, Maria [1 ]
Grande, Antonio G. [2 ]
Lopez-Plaza, Bricia [3 ]
de Miguel, Enrique [1 ]
Largo, Carlota [1 ]
Santamaria, Monica [1 ]
机构
[1] Hosp La Paz, Res Inst, Dept Expt Surg, Madrid, Spain
[2] La Paz Univ Hosp, Dept Radiat Oncol, Madrid, Spain
[3] Hosp La Paz, Res Inst, Dept Nutr, Madrid, Spain
关键词
ADULT HYPOPITUITARY PATIENTS; HUMAN MAMMARY-CARCINOMA; IN-VITRO; GENE-EXPRESSION; PRIMARY CANCERS; TREFOIL FACTOR; NUDE-MICE; RADIATION; CELLS; RAT;
D O I
10.1371/journal.pone.0144537
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The efficacy of radiotherapy on tumors is hampered by its devastating adverse effects on healthy tissue, particularly that of the gastrointestinal tract. These effects cause acute symptoms that are so disruptive to patients that they can lead to interruption of the radiotherapy program. These adverse effects could limit the intensity of radiation received by the patient, resulting in a sublethal dose to the tumor, thus increasing the risk of tumor resistance. The lack of an effective treatment to protect the bowel during radiation therapy to allow higher radiation doses that are lethal to the tumor has become a barrier to implementing effective therapy. In this study, we present a comparative analysis of both intestinal and tumor tissue in regard to the efficacy and the preventive impact of a short-term growth hormone (GH) treatment in tumor-bearing rats as a protective agent during radiotherapy. Our data show that the exogenous administration of GH improved intestinal recovery after radiation treatment while preserving the therapeutic effect against the tumor. GH significantly increased proliferation in the irradiated intestine but not in the irradiated tumors, as assessed by Positron Emission Tomography and the proliferative markers Ki67, cyclin D3, and Proliferating Cell Nuclear Antigen. This proliferative effect was consistent with a significant increase in irradiated intestinal villi and crypt length. Furthermore, GH significantly decreased caspase-3 activity in the intestine, whereas GH did not produce this effect in the irradiated tumors. In conclusion, short-term GH treatment protects the bowel, inducing proliferation while reducing apoptosis in healthy intestinal tissue and preserving radiotherapy efficacy on tumors.
引用
收藏
页数:19
相关论文
共 62 条
[1]   Chemotherapy- and radiotherapy-induced intestinal damage is regulated by intestinal trefoil factor [J].
Beck, PL ;
Wong, JF ;
Li, Y ;
Swaminathan, S ;
Xavier, RJ ;
Devaney, KL ;
Podolsky, DK .
GASTROENTEROLOGY, 2004, 126 (03) :796-808
[2]   Insulin regulation of growth hormone receptor gene expression. Evidence for a transcriptional mechanism of down-regulation in rat hepatoma cells [J].
Bennett, William L. ;
Ji, Shaonin ;
Messina, Joseph L. .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2007, 274 (1-2) :53-59
[3]  
Booth D, 2001, J Natl Cancer Inst Monogr, P16
[4]   Long-Term Mortality after Recombinant Growth Hormone Treatment for Isolated Growth Hormone Deficiency or Childhood Short Stature: Preliminary Report of the French SAGhE Study [J].
Carel, Jean-Claude ;
Ecosse, Emmanuel ;
Landier, Fabienne ;
Meguellati-Hakkas, Djamila ;
Kaguelidou, Florentia ;
Rey, Gregoire ;
Coste, Joel .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (02) :416-425
[5]   Age- and irradiation-associated loss of bone marrow hematopoietic function in mice is reversed by recombinant human growth hormone [J].
Carlo-Stella, C ;
Di Nicola, M ;
Milani, R ;
Longoni, P ;
Milanesi, M ;
Bifulco, C ;
Stucchi, C ;
Guidetti, A ;
Cleris, L ;
Formelli, F ;
Garotta, G ;
Gianni, AM .
EXPERIMENTAL HEMATOLOGY, 2004, 32 (02) :171-178
[6]   Growth Hormone Mitigates against Lethal Irradiation and Enhances Hematologic and Immune Recovery in Mice and Nonhuman Primates [J].
Chen, Benny J. ;
Deoliveira, Divino ;
Spasojevic, Ivan ;
Sempowski, Gregory D. ;
Jiang, Chen ;
Owzar, Kouros ;
Wang, Xiaojuan ;
Gesty-Palmer, Diane ;
Cline, J. Mark ;
Bourland, J. Daniel ;
Dugan, Greg ;
Meadows, Sarah K. ;
Daher, Pamela ;
Muramoto, Garrett ;
Chute, John P. ;
Chao, Nelson J. .
PLOS ONE, 2010, 5 (06)
[7]  
Chen JY, 2004, WORLD J GASTROENTERO, V10, P1132
[8]   Incidence of primary cancers and intracranial tumour recurrences in GH-treated and untreated adult hypopituitary patients: analyses from the Hypopituitary Control and Complications Study [J].
Child, Christopher J. ;
Conroy, Daniel ;
Zimmermann, Alan G. ;
Woodmansee, Whitney W. ;
Erfurth, Eva Marie ;
Robison, Leslie L. .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2015, 172 (06) :779-790
[9]   Assessment of primary cancers in GH-treated adult hypopituitary patients: an analysis from the Hypopituitary Control and Complications Study [J].
Child, Christopher J. ;
Zimmermann, Alan G. ;
Woodmansee, Whitney W. ;
Green, Daniel M. ;
Li, Jian J. ;
Jung, Heike ;
Erfurth, Eva Marie ;
Robison, Leslie L. .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2011, 165 (02) :217-223
[10]   Growth hormone protects the intestines but not the tumour from 5-fluorouracil toxicity in the short term in the rat [J].
Clavijo, J ;
Gomez-de-Segura, IA ;
Gomez-García, L ;
Vallejo-Cremades, MT ;
Sanchez, M ;
de Miguel, E .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2004, 16 (01) :75-82